Patents Assigned to Institut de Recherche pour le Development (IRD)
  • Patent number: 9234209
    Abstract: The invention relates to the use of a gene of the Argonaute family, a transcript of said gene or the ORF of said gene in order to produce plants that are completely or partially apomictic. The invention can be used to control apomixis in cultivated species having sexual reproduction.
    Type: Grant
    Filed: October 21, 2010
    Date of Patent: January 12, 2016
    Assignee: INSTITUT DE RECHERCHE POUR LE DEVELOPMENT (IRD)
    Inventors: Daniel Grimanelli, Olivier Leblanc
  • Patent number: 8569362
    Abstract: The present invention relates to a polyketide molecule of the following formula (I): or a pharmaceutically acceptable salt thereof, where R1 is a hydrogen atom or a (C1-C7) alkyl group, as well as the method of preparation and use thereof, in particular as an anticancer agent.
    Type: Grant
    Filed: October 28, 2010
    Date of Patent: October 29, 2013
    Assignees: Pierre Fabre Medicament, Centre National de la Recherche Scientifique (CNRS), Institut de Recherche pour le Development (IRD)
    Inventors: Isabelle Carletti, Georges Massiot, Cécile Debitus
  • Patent number: 8563008
    Abstract: The disclosure provides novel antigens involved in gestational malaria, and more particularly to polynucleotide and polypeptide sequences, conjugates, cloning vectors including the sequences for the preparation of immunogenic compositions and vaccines, antibodies, and to their for treating gestational malaria. Diagnostic methods and kits are described.
    Type: Grant
    Filed: April 17, 2008
    Date of Patent: October 22, 2013
    Assignees: Institut de Recherche pour le Development (IRD), Institut Pasteur
    Inventors: Philippe Lucien Deloron, Nicaise George Tuikue Ndam, Gwladys Irénée Bertin, Peter David, Emmanuel Bischoff, Caroline Stéphanie Proux, Jean-Yves Coppee, Ali Salanti, Thomas Lavstsen
  • Publication number: 20120316102
    Abstract: The present invention relates to an antimicrobial peptide characterised in that said peptide includes the sequence SEQ ID No. 1 or the sequence SEQ ID No. 2, the sequence SEQ ID No. 2 representing a fragment of the sequence SEQ ID No. 1, for use as a drug. Advantageously according to the invention, the peptide having sequence SEQ ID No. 1 is used specifically for treating bacterial, viral and/or parasitic infections, and the peptide having sequence SEQ No. 2 is used for treating bacterial and/or viral infections.
    Type: Application
    Filed: February 3, 2011
    Publication date: December 13, 2012
    Applicant: Institut de Recherche pour le Development (IRD)
    Inventors: Marthe Dorothée Misse Brumas, Natthanej Luplertlop, Hans Yssel, Frédéric Thomas, François Renaud
  • Patent number: 7862721
    Abstract: A process for the decontamination of an effluent containing one or more dissolved metals is provided. The process includes producing hydrogen sulphide in an aqueous medium by culturing alkaliphilic sulphate-reducing or thio-sulphate reducing bacteria in the presence of an organic compound serving as an electron donor and in the presence of a sulphurous compound serving as an electron acceptor. The effluent is contacted with the hydrogen sulphide and the dissolved metals are reduced and/or precipitated in the form of metal sulphides.
    Type: Grant
    Filed: August 16, 2010
    Date of Patent: January 4, 2011
    Assignee: Institut de Recherche pour le Development (IRD)
    Inventors: Bernard Marcel Noel Ollivier, Yannick Aman Baptiste Combet-Blanc, Marie-Laure Fardeau, Bruno Chardin